The FDA said said a proposed experimental drug being developed by a unit of J&J to treat a drug-resistant form of tuberculosis appeared "safe and well-tolerated."
WSJ.com: What's News US, Wall Street Journal
Mon, 11/26/2012 - 7:47am
The FDA said said a proposed experimental drug being developed by a unit of J&J to treat a drug-resistant form of tuberculosis appeared "safe and well-tolerated."